Product
CD19 CAR NK cells
1 clinical trial
1 indication
Indication
Autoimmune DiseasesClinical trial
An Exploratory Clinical Study of the Safety and Efficacy of CD19 Chimeric Antigen Receptor NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesStatus: Not yet recruiting, Estimated PCD: 2025-06-30